bevacizumab,olaparib
astrazeneca,merck,roche
['gyn', 'ovarian', 'paola-1']
top story: : 'paola-1 presented at oral gyneacological session of 2022.
5-years overall survival was prolongated for half of the patients with ovarian cancer. one of the major step forward since 25 ye see more 
evaluator-manager-researcher-learner- polyglot-creative Mumx3 | enchanted by arts culture societies politic | “#Research is the creation of new #knowledge” (NA)